A randomized pilot study comparing safety and efficacy of irinotecan plus S-1 plus bevacizumab (IRIS+BV) and modified FOLFIRI plus BV (mFOLFIRI+BV) in patients (pts) with metastatic colorectal cancer (mCRC): The result of efficacy report of T-CORE0702.
Year: 2011
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: H. Andoh, S. Kato, M. Gamoh, T. Yamaguchi, M. Sakayori, Y. Sasaki, T. Mori, H. Ohori, T. Yoshioka, C. Ishioka
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2201821118